"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...

Study links hallucinogen use to higher schizophrenia risk, highlighting the need for caution and informed decisions on ...

The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

A trio of risk factors not only increase your risk of stroke, but they also raise the odds that such a stroke will be ...

The following is a summary of “Engagement in a virtual group-based walking intervention for persons with schizophrenia: a qualitative study,” published in the November 2024 issue of Psychiatry by ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

Among individuals with schizophrenia, the risk for natural-cause mortality was increased in those with reduced cognitive functioning.

A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to ...

ED visits related to hallucinogen use are linked to a 21-fold increased risk of schizophrenia spectrum disorder, results of a ...